Healthcare

UK considers continuous monitoring for healthcare AI

The UK is moving toward continuous monitoring of AI used in healthcare as regulators respond to rapidly changing systems. The policy direction emphasises oversight after deployment as well as before approval.

The UK’s healthcare AI policy discussion is moving toward continuous monitoring of systems used in medical settings. The change is part of a wider regulatory response to AI’s rapid evolution and its increasing use in healthcare.

Continuous monitoring differs from a one-time assessment because systems can be updated, retrained, connected to new data or applied in new clinical contexts after initial deployment. Those changes can affect performance and risk.

The policy direction is relevant to developers and healthcare providers that must demonstrate how systems behave in practice. It also places greater emphasis on post-deployment evidence, incident reporting and mechanisms for responding when performance falls short.

For patients and clinicians, the approach addresses the possibility that an AI tool’s safety profile may change over time. The development shows regulators treating operational oversight as an ongoing requirement for healthcare AI rather than an issue resolved at product launch.

Original source: Fox News

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI